Market revenue in 2023 | USD 100.7 million |
Market revenue in 2030 | USD 251.6 million |
Growth rate | 14% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Sequencing & Data Analytics Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Kits & reagents was the largest segment with a revenue share of 61.57% in 2023. Horizon Databook has segmented the UK metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The UK metagenomics market is expected to grow in tandem with the overall European market owing to increasing development of companion diagnostics and subsequent establishment of molecular diagnostic development facilities by key market players.
Furthermore, ongoing strategic alliances between players in European and eastern markets are expected to fuel the region’s metagenomics market during the forecast period.
Consequently, the UK follows Germany, and with the expected implementation of nationwide Europe WGS projects in the coming years, the UK metagenomics market is expected to witness substantial growth in the coming years.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account